FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385407134> ?p ?o ?g. }

• W4385407134 endingPage "2664" @default.
• W4385407134 startingPage "2657" @default.
• W4385407134 abstract "Patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC) receiving definitive concurrent chemoradiation therapy (CCRT) benefit from durvalumab consolidation therapy. However, predictive factors for early relapse during durvalumab maintenance have not yet been identified.The present study included the lung cancer cohort of the Catholic Medical Centers at the Catholic University of Korea from January 2018 to December 2021. A total of 51 NSCLC patients treated with durvalumab consolidation therapy after definitive CCRT were included in the analysis. Early relapse was defined as patients experiencing relapse within 6 months of starting initial durvalumab therapy.Among the 51 patients, 15 (29.4%) relapsed during the study period. Median time from initial therapy of durvalumab to progression was 451.00 ± 220.87 days (95% confidence interval [CI]: 18.10-883.90) in overall patients. In multivariate analysis, younger age (adjusted odds ratio [aOR], 0.792; 95% CI: 0.642-0.977; p = 0.030), higher pack-years (aOR, 1.315; 95% CI: 1.058-1.635; p = 0.014), non-COPD (aOR, 0.004; 95% CI: 0.000-0.828; p = 0.004) and anemia (aOR, 234.30; 95% CI: 1.212-45280.24; p = 0.042), were independent predictive factors for early relapse during durvalumab consolidation therapy.Younger age, higher number of pack-years, non-COPD, and anemia were independent predictive factors for early relapse during durvalumab consolidation therapy in patients with unresectable stage III NSCLC after definitive CCRT. Careful patient selection and clinical attention are needed for high-risk individuals." @default.
• W4385407134 created "2023-08-01" @default.
• W4385407134 creator A5000364219 @default.
• W4385407134 creator A5006147087 @default.
• W4385407134 creator A5033943394 @default.
• W4385407134 creator A5035493748 @default.
• W4385407134 creator A5057467146 @default.
• W4385407134 creator A5070077415 @default.
• W4385407134 creator A5071284791 @default.
• W4385407134 creator A5083127780 @default.
• W4385407134 creator A5085621981 @default.
• W4385407134 creator A5088784469 @default.
• W4385407134 date "2023-07-30" @default.
• W4385407134 modified "2023-09-29" @default.
• W4385407134 title "Identification of predictive factors for early relapse in patients with unresectable stage <scp>III non‐small cell lung cancer</scp> receiving consolidation durvalumab after concurrent chemoradiation therapy" @default.
• W4385407134 cites W1969556995 @default.
• W4385407134 cites W1971146628 @default.
• W4385407134 cites W1973132357 @default.
• W4385407134 cites W1978023782 @default.
• W4385407134 cites W2005383143 @default.
• W4385407134 cites W2021555652 @default.
• W4385407134 cites W2037651840 @default.
• W4385407134 cites W2049014568 @default.
• W4385407134 cites W2054315097 @default.
• W4385407134 cites W2082424649 @default.
• W4385407134 cites W2085086439 @default.
• W4385407134 cites W2101697047 @default.
• W4385407134 cites W2132889938 @default.
• W4385407134 cites W2150472441 @default.
• W4385407134 cites W2510866512 @default.
• W4385407134 cites W2586810147 @default.
• W4385407134 cites W2753065806 @default.
• W4385407134 cites W2759987239 @default.
• W4385407134 cites W2783402234 @default.
• W4385407134 cites W2893870376 @default.
• W4385407134 cites W2903609600 @default.
• W4385407134 cites W2910521769 @default.
• W4385407134 cites W2945234096 @default.
• W4385407134 cites W2981067716 @default.
• W4385407134 cites W3001408868 @default.
• W4385407134 cites W3082921284 @default.
• W4385407134 cites W3121852242 @default.
• W4385407134 cites W3126239108 @default.
• W4385407134 cites W3129132496 @default.
• W4385407134 cites W3131416308 @default.
• W4385407134 cites W3133581524 @default.
• W4385407134 cites W3140204983 @default.
• W4385407134 cites W3142040693 @default.
• W4385407134 cites W3166471470 @default.
• W4385407134 cites W3194209405 @default.
• W4385407134 cites W3197329693 @default.
• W4385407134 cites W3214539747 @default.
• W4385407134 cites W4226175083 @default.
• W4385407134 cites W4280533169 @default.
• W4385407134 cites W4283015181 @default.
• W4385407134 cites W4306405632 @default.
• W4385407134 cites W4307233602 @default.
• W4385407134 cites W4385407134 @default.
• W4385407134 doi "https://doi.org/10.1111/1759-7714.15050" @default.
• W4385407134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37519059" @default.
• W4385407134 hasPublicationYear "2023" @default.
• W4385407134 type Work @default.
• W4385407134 citedByCount "1" @default.
• W4385407134 countsByYear W43854071342023 @default.
• W4385407134 crossrefType "journal-article" @default.
• W4385407134 hasAuthorship W4385407134A5000364219 @default.
• W4385407134 hasAuthorship W4385407134A5006147087 @default.
• W4385407134 hasAuthorship W4385407134A5033943394 @default.
• W4385407134 hasAuthorship W4385407134A5035493748 @default.
• W4385407134 hasAuthorship W4385407134A5057467146 @default.
• W4385407134 hasAuthorship W4385407134A5070077415 @default.
• W4385407134 hasAuthorship W4385407134A5071284791 @default.
• W4385407134 hasAuthorship W4385407134A5083127780 @default.
• W4385407134 hasAuthorship W4385407134A5085621981 @default.
• W4385407134 hasAuthorship W4385407134A5088784469 @default.
• W4385407134 hasBestOaLocation W43854071341 @default.
• W4385407134 hasConcept C121608353 @default.
• W4385407134 hasConcept C126322002 @default.
• W4385407134 hasConcept C143998085 @default.
• W4385407134 hasConcept C146357865 @default.
• W4385407134 hasConcept C151730666 @default.
• W4385407134 hasConcept C156957248 @default.
• W4385407134 hasConcept C2776256026 @default.
• W4385407134 hasConcept C2777701055 @default.
• W4385407134 hasConcept C2777742743 @default.
• W4385407134 hasConcept C2780030458 @default.
• W4385407134 hasConcept C71924100 @default.
• W4385407134 hasConcept C86803240 @default.
• W4385407134 hasConceptScore W4385407134C121608353 @default.
• W4385407134 hasConceptScore W4385407134C126322002 @default.
• W4385407134 hasConceptScore W4385407134C143998085 @default.
• W4385407134 hasConceptScore W4385407134C146357865 @default.
• W4385407134 hasConceptScore W4385407134C151730666 @default.
• W4385407134 hasConceptScore W4385407134C156957248 @default.
• W4385407134 hasConceptScore W4385407134C2776256026 @default.
• W4385407134 hasConceptScore W4385407134C2777701055 @default.
• W4385407134 hasConceptScore W4385407134C2777742743 @default.
• W4385407134 hasConceptScore W4385407134C2780030458 @default.

• next